Abstract

The majority of patients in each group discontinued their assigned treatment owing to inefficacy or intolerable side effects or for other reasons. Olanzapine was the most effective in terms of the rates of discontinuation, and the efficacy of the conventional antipsychotic agent perphenazine appeared similar to that of quetiapine, risperidone, and ziprasidone. Olanzapine was associated with greater weight gain and increases in measures of glucose and lipid metabolism.

Keywords

ZiprasidoneQuetiapineOlanzapineRisperidonePerphenazineMedicineDiscontinuationAntipsychoticInternal medicineAtypical antipsychoticClozapineSchizophrenia (object-oriented programming)PsychiatryAnesthesiaPharmacology

Affiliated Institutions

Related Publications

Publication Info

Year
2005
Type
article
Volume
353
Issue
12
Pages
1209-1223
Citations
5834
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

5834
OpenAlex

Cite This

Jeffrey A. Lieberman, T. Scott Stroup, Joseph P. McEvoy et al. (2005). Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia. New England Journal of Medicine , 353 (12) , 1209-1223. https://doi.org/10.1056/nejmoa051688

Identifiers

DOI
10.1056/nejmoa051688